Related Experiment Video
Updated: Apr 23, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Contraception for women with heart disease
R Bonassi Machado1, N Santana, M Gonzaga
1Department of Gynecology and Obstetrics Jundiaí Medical School, Jundiaí São Paulo, Brazil - rogeriobonassi@terra.com.br.
This review offers guidance on safe contraceptive choices for women with heart disease, addressing uncertainties in pregnancy risk counseling and optimal method selection for clinicians.
Area of Science:
- Cardiology
- Reproductive Health
- Clinical Practice
Background:
- Limited research exists on contraceptive use in women with heart disease.
- This gap creates uncertainty for healthcare providers counseling on pregnancy risks and contraceptive options.
- The number of women of reproductive age with cardiac conditions is increasing.
Purpose of the Study:
- To provide practical guidance for clinicians on safe contraceptive choices for women with heart disease.
- To address uncertainties regarding pregnancy risk and optimal family planning in this patient population.
- To support cardiologists, obstetricians, general practitioners, and family planning specialists.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on the topic.
- Focuses on practical clinical guidance.
Main Results:
- Cardiomyopathy and heart disease present unique challenges for family planning.
- Certain contraceptive methods may pose higher risks for women with specific cardiac conditions.
- Effective counseling requires understanding individual patient risk factors.
Conclusions:
- Safe and effective contraceptive options are available for most women with heart disease.
- Personalized counseling is crucial for managing pregnancy risks and selecting appropriate contraception.
- Further research is needed to refine guidelines and address specific cardiac conditions.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Birth Control Methods
Coronary Artery Disease IV: Preventive Measures
Cardiovascular Drugs: Classification based on Therapeutic Indications
Rheumatic Heart Disease III: Medical Management
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Adrenergic Antagonists: ɑ and β-Receptor Blockers